Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Clinical trial NCT00642174 · COMPLETED

Trial details

NCT number: NCT00642174
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Coronary Artery Disease

Start date: 2008-04-01
Primary completion: 2009-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.